The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
Status:
Withdrawn
Trial end date:
2018-03-05
Target enrollment:
Participant gender:
Summary
Patients with severe chronic kidney disease (CKD) who develop atrial fibrillation are at high
risk for stroke. The use of blood thinking medication in dialysis patients is controversial
and warfarin carries a serious risk for major bleeding.
The Watchman device may be an ideal therapy for this population as after implantation it
allows for the discontinuation of blood thinners, thereby reducing the risk of bleeding.